Why the AstraZeneca-Oxford vaccine is different

 Why the AstraZeneca-Oxford vaccine is different
Want us to send our biggest stories straight to your inbox?

“,”buttonText”:”Sign up for regular updates and breaking news from WalesOnline”,”contentId”:9966081,”newsletterImage”:”https://i2-prod.walesonline.co.uk/incoming/article19233453.ece/BINARY/0_JS222398518.jpg”,”endpointUrl”:”https://response.pure360.com/interface/list.php”,”profile”:”Wales_Online”,”isPure360NewsLetter”:true,”pure360MailingListId”:”Wales Online – Daily Newsletter”,”newsletterSiteName”:”Wales Online”}” data-mod=”skinnySignup”>

When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.

Invalid Email

Scientists around the world are racing to create a vaccine for Covid-19, and one of the leading contenders is the UK jab being developed by Oxford University and the Anglo-Swedish pharmaceutical company AstraZeneca.

The AstraZeneca-Oxford vaccine as it’s come to be known has been making headlines all week – but not all have been positive.

The team behind the jab initially announced it had an overall 70 per cent success rate at preventing Covid-19 but that rates varied from 62 per cent to 90 per cent depending on the dose given.

It then emerged some test patients had been given a lower does than they should have by accident – but these were the ones with the higher efficacy. There have also been questions about the relatively small number given the lower, more effective dosing regime, and the fact tha

Read More

Redak staff

Leave a Reply

Your email address will not be published.